Akso Health vs Agape ATP
Akso Health is the larger business, with $13.8m of revenue in fiscal 2026 against $1.5m for Agape ATP (9.1 times as much). Agape ATP grew faster (15.2% against -6.4%). Akso Health kept more of each dollar of sales as profit: a net margin of -135.0% against -149.6%.
| Latest fiscal year | Akso HealthAHG, 2026 | Agape ATPATPC, 2025 |
|---|---|---|
| Revenue | $13.8m | $1.5m |
| Revenue growth | -6.4% | 15.2% |
| Net income | −$18.7m | −$2.3m |
| Operating margin | — | -213.7% |
| Net margin | -135.0% | -149.6% |
| Return on equity | -9.8% | -18.7% |
| Free cash flow | −$12.8m | −$2.4m |
| Cash | $170,572 | $89,651 |
| Total debt | $0 | $0 |
| Debt to equity | — | 0.0% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | — | 18 |
| Market value | $949m | $1.3m |
| Price vs our value range | — | — |
| Moat score | — | 33 (Weak) |
| Insider trades, 12 months | 0 buys, 0 sales | 0 buys, 0 sales |